UNC's Siderovski wins pharmacology award

March 25, 2004

CHAPEL HILL -- The American Society for Pharmacology and Experimental Therapeutics has named Dr. David P. Siderovski, assistant professor of pharmacology in The University of North Carolina at Chapel Hill School of Medicine, the recipient of the 2004 John J. Abel Award.

Siderovski, a member of the UNC Lineberger Comprehensive Cancer Center and the UNC Neuroscience Center, "receives the award as an outstanding young investigator for his contributions that helped shape the field of pharmacology," society officials said.

In 1996, while head of the Quantitative Biology Laboratory at the Amgen Institute in Toronto, Siderovski discovered a new family of proteins, RGS proteins, that accelerates the shutoff of cell signaling pathways.

He continues his basic research program at UNC using biochemistry, structural biology and genetics to understand how RGS proteins control the timing of physiological events. His studies are aimed at drug target discovery and drug development.

The award, sponsored by Eli Lilly and Co., is considered the most prestigious award for young scientists in pharmacology and experimental therapeutics.

This is Siderovski's third national career award since joining the UNC faculty in 1999. He was named a Year 2000 Neuroscience Scholar by the EJLB Foundation of Montreal and in 2001 received a New Investigator Award in Basic Pharmacological Sciences by the Burroughs Wellcome Fund.

Siderovski receives the newest award, which carries a $2,500 stipend, April 17 at the society's annual meeting in Washington, D.C. note: contact Siderovski at 843-9363 or david_siderovski@med.unc.edu School of Medicine contact, Les Lang, 919-843-9687 or llang@med.unc.edu

University of North Carolina Health Care

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.